Glaxosmithkline Plc (NY: GSK )
39.24
USD
+0.32
(+0.82%)
Official Closing Price
Updated: 7:59 PM EST, Jan 26, 2021
Add to My Watchlist
Stories about Glaxosmithkline Plc
Dr. Fauci urges Americans to make sacrifices: ‘Thanksgiving is going to look very different this year’
October 15, 2020
From MarketWatch
Big Pharma's Vaccine Race – A Chance For Redemption
October 15, 2020
From Benzinga
Bracing for a cold winter, New Yorkers don’t hold out much hope that the city will recover from COVID-19 anytime soon
October 15, 2020
From MarketWatch
Dr. Fauci: ‘This is an outbreak of historic proportions, the likes of which we’ve not seen in 102 years’
October 13, 2020
From MarketWatch
Trump’s vaccine czar says the first vaccine should be submitted for emergency authorization around Thanksgiving
October 08, 2020
From MarketWatch
Daily Stock Analysis: GlaxoSmithKline
October 07, 2020
From Blogs - TalkMarkets
Coronavirus update: U.S. death toll tops 210,000 as doctors say Trump’s comments on COVID-19 are sending the wrong message
October 06, 2020
From MarketWatch
Vir Biotech, GlaxoSmithKline Advance COVID-19 Antibody Treatment Into Global, Late-Stage Trial
October 06, 2020
From Benzinga
‘Don’t ever, ever underestimate the potential of the pandemic’: 5 reasons scientists say you should be afraid of COVID-19
October 06, 2020
From MarketWatch
COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' Supercomputer
October 06, 2020
From Benzinga
From Motley Fool
‘This is the height of irresponsibility’: Doctors react to Trump’s motorcade outside Walter Reed to wave at supporters
October 05, 2020
From MarketWatch
‘We’re getting great reports from the doctors’: Trump tweets second video from Walter Reed
October 04, 2020
From MarketWatch
‘I wasn’t feeling so well. I feel much better now’: Full transcript of Trump’s video address from Walter Reed
October 04, 2020
From MarketWatch
Trump tests positive for coronavirus — why he’s at higher risk of more severe illness from COVID-19
October 02, 2020
From MarketWatch
Bayer’s Dismal M&A Harvest Boosts Breakup Pressure
October 02, 2020
From Blogs - TalkMarkets
As Trump tests positive for coronavirus — a look back at his statements on face masks and growing threat of COVID-19
October 02, 2020
From MarketWatch
FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, Reuters reports
October 01, 2020
From MarketWatch
Cholera vaccines Market Overview and Competitive Analysis -Astellas Pharma Inc., AstraZeneca, Emergent BioSolutions Inc., GlaxoSmithKline plc (GSK)
October 01, 2020
From X herald
This Revolutionary Sector Is Transforming the Market Itself – Here’s How You Can Cash in On It
September 30, 2020
From Blogs - TalkMarkets
Better Buy: GlaxoSmithKline vs. Pfizer
September 30, 2020
From Motley Fool
Regeneron Says COVID-19 Antibody Cocktail Helped Non-Hospitalized Patients Heal Faster In Early Trials
September 29, 2020
From Benzinga
Top Biotech Stocks To Watch Before October Amid COVID-19 Vaccine Race
September 29, 2020
From Stockmarket.com
TalkMarkets Tuesday Talk: Dips, Swings and The Election
September 29, 2020
From Blogs - TalkMarkets
Biotech Stock Playbook In A Choppy Momentum Market
September 29, 2020
From Blogs - TalkMarkets
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
September 26, 2020
From Benzinga
Better Coronavirus Stock: BioNTech or Vir Biotechnology?
September 26, 2020
From Motley Fool
There are four coronavirus vaccines in late-stage studies; here’s how they differ
September 25, 2020
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.